# Influence of Exceptional Patient Characteristics on Everolimus Exposure

> **NCT01948960** · PHASE4 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 56 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** everolimus dose escalation

## Key facts

- **NCT ID:** NCT01948960
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2018-01-15
- **Final completion:** 2018-01-15
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2018-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01948960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01948960, "Influence of Exceptional Patient Characteristics on Everolimus Exposure". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01948960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*